Englese Thomas 4
4 · AZIYO BIOLOGICS, INC. · Filed Sep 12, 2022
Insider Transaction Report
Form 4
Englese Thomas
Chief Commercial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2022-09-08+15,390→ 21,997 total - Exercise/Conversion
Restricted Stock Units
2022-09-08−15,390→ 0 total→ Class A Common Stock (15,390 underlying) - Tax Payment
Class A Common Stock
2022-09-08$7.30/sh−4,728$34,514→ 17,269 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
- [F2]Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
- [F3]The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.